Denitsa Milanova
President chez Marble Therapeutics, Inc.
Profil
Denitsa M.
Milanova is an Independent Non-Executive Director at InSilico Medicine Cayman TopCo and holds the positions of President, Treasurer, Director & Vice President at Marble Therapeutics, Inc. She received her doctorate degree from Stanford University in 2016 and her undergraduate degree from the University of Central Florida in 2008.
Postes actifs de Denitsa Milanova
| Sociétés | Poste | Début |
|---|---|---|
Insilico Medicine Cayman TopCo
 Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Directeur/Membre du Conseil | 01/06/2023 |
Marble Therapeutics, Inc.
 Marble Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Marble Therapeutics, Inc. develops gene therapies. The company is based in Boston, MA. | President | - |
Formation de Denitsa Milanova
| Stanford University | Doctorate Degree |
| University of Central Florida | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Insilico Medicine Cayman TopCo
Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong. | Commercial Services |
Marble Therapeutics, Inc.
Marble Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Marble Therapeutics, Inc. develops gene therapies. The company is based in Boston, MA. | Commercial Services |